| | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H29N3O |
| Molar mass | 387.527 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CUMYL-NBMINACA (SGT-152, Cumyl-BC[2.2.1]HpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent, [1] but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021. [2] [3]